Johnson & Johnson Free Cash Flow 2010-2024 | JNJ

Johnson & Johnson free cash flow for the twelve months ending September 30, 2024 was , a year-over-year.

  • Johnson & Johnson annual free cash flow for 2023 was $18.606B, a 4.95% increase from 2022.
  • Johnson & Johnson annual free cash flow for 2022 was $17.728B, a 13.39% decline from 2021.
  • Johnson & Johnson annual free cash flow for 2021 was $20.469B, a 0.12% decline from 2020.

Johnson & Johnson Free Cash Flow 2010-2024 | JNJ

  • Johnson & Johnson annual free cash flow for 2023 was $18.606B, a 4.95% increase from 2022.
  • Johnson & Johnson annual free cash flow for 2022 was $17.728B, a 13.39% decline from 2021.
  • Johnson & Johnson annual free cash flow for 2021 was $20.469B, a 0.12% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$753.9B
Novo Nordisk (NVO)$393.3B
AbbVie (ABBV)$316.7B
Merck (MRK)$252.6B
AstraZeneca (AZN)$206.3B
Novartis AG (NVS)$201.1B
Pfizer (PFE)$150.5B
Sanofi (SNY)$122.9B
Bayer (BAYRY)$19.1B
Innoviva (INVA)$1.1B